Aadi Historical Balance Sheet
| AADI Stock | USD 2.31 0.09 4.05% |
Trend analysis of Aadi Bioscience balance sheet accounts such as Total Stockholder Equity of 110.5 M, Cash of 66 M or Cash And Short Term Investments of 114.3 M provides information on Aadi Bioscience's total assets, liabilities, and equity, which is the actual value of Aadi Bioscience to its prevalent stockholders. By breaking down trends over time using Aadi Bioscience balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Aadi Bioscience latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aadi Bioscience is a good buy for the upcoming year.
Aadi Bioscience Inventory |
|
Aadi |
About Aadi Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Aadi Bioscience at a specified time, usually calculated after every quarter, six months, or one year. Aadi Bioscience Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Aadi Bioscience and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Aadi currently owns. An asset can also be divided into two categories, current and non-current.
Aadi Bioscience Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Aadi Bioscience assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Aadi Bioscience books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Accounts Payable
An accounting item on the balance sheet that represents Aadi Bioscience obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Aadi Bioscience are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Short Term Investments
Short Term Investments is an item under the current assets section of Aadi Bioscience balance sheet. It contains any investments Aadi Bioscience undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Aadi Bioscience can easily liquidate in the marketplace.Most accounts from Aadi Bioscience's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Aadi Bioscience current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.As of now, Aadi Bioscience's Cash And Short Term Investments are increasing as compared to previous years. The Aadi Bioscience's current Common Stock Shares Outstanding is estimated to increase to about 28.3 M, while Net Debt is forecasted to increase to (58.5 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Current Assets | 151.3M | 180.0M | 124.6M | 130.8M | Other Stockholder Equity | 279.1M | 361.7M | 374.1M | 392.8M |
Aadi Bioscience balance sheet Correlations
Click cells to compare fundamentals
Aadi Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aadi Bioscience balance sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 39.9M | 18.8M | 157.9M | 184.2M | 132.4M | 139.0M | |
| Total Stockholder Equity | 36.5M | (12.4M) | 136.4M | 158.4M | 105.2M | 110.5M | |
| Net Debt | (38.4M) | 5.8M | (148.4M) | (37.4M) | (61.6M) | (58.5M) | |
| Retained Earnings | (142.2M) | (32.6M) | (142.7M) | (203.2M) | (269.0M) | (255.5M) | |
| Cash | 38.5M | 4.5M | 149.0M | 39.0M | 62.9M | 66.0M | |
| Cash And Short Term Investments | 38.5M | 4.5M | 149.0M | 172.6M | 108.8M | 114.3M | |
| Common Stock Shares Outstanding | 2.7M | 2.5M | 8.9M | 22.5M | 26.9M | 28.3M | |
| Liabilities And Stockholders Equity | 39.9M | 18.8M | 157.9M | 184.2M | 132.4M | 139.0M | |
| Other Stockholder Equity | 179.1M | 20.2M | 279.1M | 361.7M | 374.1M | 392.8M | |
| Total Current Assets | 39.6M | 18.7M | 151.3M | 180.0M | 124.6M | 130.8M | |
| Total Current Liabilities | 3.3M | 30.1M | 15.3M | 18.8M | 26.4M | 27.7M | |
| Total Liab | 3.4M | 31.3M | 21.5M | 25.9M | 27.2M | 28.6M | |
| Other Current Liab | 2.8M | 99K | 8.7M | 14.5M | 20.1M | 21.1M | |
| Accounts Payable | 439.8K | 2.4M | 6.4M | 3.5M | 5.9M | 6.2M | |
| Other Current Assets | 1.0M | 81K | 4.6M | 3.7M | 3.8M | 4.0M | |
| Non Current Assets Total | 366.3K | 140K | 6.6M | 4.2M | 7.8M | 8.2M | |
| Non Currrent Assets Other | 40.0K | (140K) | 2.2M | 2.1M | 1.9M | 2.0M | |
| Property Plant And Equipment Net | 326.3K | 140K | 614K | 2.0M | 6.0M | 6.3M | |
| Accumulated Other Comprehensive Income | (335.8K) | (311.1K) | (328.9K) | (115K) | 27K | 28.4K | |
| Property Plant And Equipment Gross | 326.3K | 185.6K | 614K | 2.0M | 6.2M | 6.6M | |
| Net Tangible Assets | (9.1M) | 43.1M | 132.6M | 158.4M | 182.1M | 191.2M | |
| Property Plant Equipment | 316.0K | 121.7K | 57K | 2.0M | 2.3M | 2.5M |
Currently Active Assets on Macroaxis
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Revenue Per Share 0.929 | Quarterly Revenue Growth 0.21 | Return On Assets (0.35) | Return On Equity (0.66) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.